*2.6.2 Risks*

The risks associated with COC use are influenced by the type and dose of estrogen and progestogen contained in the formulation. These risks are as follows:


sexual exposure the likely risk factor for these infections and not the contraceptive method. Other studies have reported reduced rates of bacterial vaginosis in women using COCs. Data generally do not support any influence of COC use on the acquisition of HIV. There are currently no restrictions on COC use among women with STIs, PID, or HIV [48–50].
